Dr. Cass on Managing Diarrhea in Patients Treated With EGFR TKIs
Amanda Cass, PharmD, BCPS, BCOP, discusses strategies to manage the diarrhea that may occur as an adverse effect in patients treated with EGFR TKIs.
EP: 1.Emily Skotte, MSN on Rash Management in Patients Treated With EGFR TKIs
EP: 2.Dr. Cass on Managing Diarrhea in Patients Treated With EGFR TKIs
EP: 3.Dr. Piotrowska on the Management of Paronychia Associated With EGFR TKIs
EP: 4.Best Practices for Managing EGFR Tyrosine Kinase Inhibitor–Related Adverse Events
EP: 5.Experts Discuss Management of Skin and Mouth TRAEs Associated With EGFR TKIs
EP: 6.Experts Discuss the Risk of Skin Toxicities Associated With EGFR TKIs
EP: 7.Experts Discuss Common AEs With EGFR TKIs
EP: 8.Experts Discuss the Safety Profile of Mobocertinib in EGFR Exon 20–Mutated Advanced NSCLC
EP: 9.Experts Discuss How to Address Cardiac-Related Toxicities With EGFR TKIs
EP: 10.Experts Discuss the Management of Paronychia When Treating Patients with EGFR TKIs
EP: 11.Experts on the Management of Diarrhea Associated With EGFR TKIs
Amanda Cass, PharmD, BCPS, BCOP, clinical pharmacist, Thoracic Oncology Clinic, Vanderbilt University Medical Center, discusses strategies to manage the diarrhea that may occur as an adverse effect (AE) in patients treated with EGFR TKIs.
Instructing patients to keep imodium at home when they receive their EGFR prescription, and telling them who to call if they have issues or questions, are recommended first steps toward managing this AE, Cass says. Daily imodium may be effective in some patients, as EGFR TKIs are daily therapies, unlike intravenous chemotherapy, where patients may have AEs for a few days after they receive the therapy, and then have weeks of recovery, Cass explains.
Establishing a balance between diarrhea and constipation is important, Cass notes. For example, if a patient on adjuvant osimertinib (Tagrisso) is experiencing diarrhea, taking 1 tablet of imodium each day may result in constipation, while 1 tablet every other day may not lessen the diarrhea, Cass says. However, a more specific regimen, such as alternating between 1 tablet and half a tablet every other day, may balance out the patient’s symptoms, Cass explains.
Proactive strategies that are tailored to patients’ specific symptoms are key to managing this AE, Cass concludes.
Sponsored by Takeda Oncology
